MassMutual Private Wealth & Trust FSB Sells 160 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

MassMutual Private Wealth & Trust FSB cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 988 shares of the medical equipment provider’s stock after selling 160 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Intuitive Surgical were worth $516,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in ISRG. Mirador Capital Partners LP lifted its holdings in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares in the last quarter. M.E. Allison & CO. Inc. bought a new stake in Intuitive Surgical in the 4th quarter valued at $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical in the 4th quarter worth $82,517,000. Exome Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, Consolidated Planning Corp grew its position in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Raymond James lifted their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Piper Sandler reiterated an “overweight” rating and set a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $554.17.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 1,012 shares of the business’s stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $514.00, for a total transaction of $520,168.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,830,084. The trade was a 15.53 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 43,509 shares of company stock valued at $22,602,212. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $604.12 on Wednesday. The firm has a 50 day moving average price of $541.80 and a 200 day moving average price of $500.76. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $606.27. The company has a market capitalization of $215.18 billion, a PE ratio of 97.13, a price-to-earnings-growth ratio of 5.04 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.